Lexeo Therapeutics, Inc. (LXEO) Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia Transcript

Discusses Phase III Program Design and Durable Cardiac Improvements in Friedreich's Ataxia June 29, 2026 2:00 PM ...
La Brújula Verde

The cosmological principle says that if we look far enough, the universe is the same in every direction: a disturbing finding suggests it is not

A team of astrophysicists has just published in Nature a finding that calls into question one of the pillars of modern ...
AlphaGalileo

PLXNC1 – a novel biomarker for consensus molecular subtype 4 in colorectal cancer (CMS4 CRC)

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
BMJ Open

Protocol for the economic evaluation of integrated longitudinal public health interventions in a cluster randomised controlled trial setting: the healthy life trajectories ...

Introduction In 2021, globally, cardiometabolic diseases (CMDs) accounted for 35% of the 1.73 billion disability-adjusted life years (DALYs) attributed to non-communicable diseases. The Healthy Life ...